First Time Loading...
C

Clarus Therapeutics Holdings Inc
NASDAQ:CRXT

Watchlist Manager
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Watchlist
Price: 0.021 USD -19.54% Market Closed
Updated: Jun 10, 2024

Clarus Therapeutics Holdings Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Clarus Therapeutics Holdings Inc
Capital Expenditures Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
C
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Capital Expenditures
-$25k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Capital Expenditures
-$4.5B
CAGR 3-Years
-10%
CAGR 5-Years
-4%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Capital Expenditures
-$1.2B
CAGR 3-Years
-18%
CAGR 5-Years
-6%
CAGR 10-Years
-8%
Pfizer Inc
NYSE:PFE
Capital Expenditures
-$3.5B
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
-9%
Merck & Co Inc
NYSE:MRK
Capital Expenditures
-$3.7B
CAGR 3-Years
7%
CAGR 5-Years
-6%
CAGR 10-Years
-10%
Eli Lilly and Co
NYSE:LLY
Capital Expenditures
-$7.6B
CAGR 3-Years
-50%
CAGR 5-Years
-19%
CAGR 10-Years
-21%

See Also

What is Clarus Therapeutics Holdings Inc's Capital Expenditures?
Capital Expenditures
-25k USD

Based on the financial report for Dec 31, 2021, Clarus Therapeutics Holdings Inc's Capital Expenditures amounts to -25k USD.

What is Clarus Therapeutics Holdings Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 1Y
60%

Over the last year, the Capital Expenditures growth was 60%.